Government to Release Guideline for Review of Biopharmaceutical Products
Published: 2005-03-30 06:59:00
Updated: 2005-03-30 06:59:00
The Korea Food and Drug Administration (KFDA) announced on March 28th that it has released a comprehensive guideline with detailed evaluation procedures as specific to the safety and efficacy profiles of biopharmaceuticals and biomedicines.
Under an initiative by KFDA to expedite the commercia...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
